首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi

基因合成市場規模、佔有率和成長分析（按方法、服務、應用、最終用途和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1900364

基因合成市場規模、佔有率和成長分析（按方法、服務、應用、最終用途和地區分類）－2026-2033年產業預測

Gene Synthesis Market Size, Share, and Growth Analysis, By Method (Solid-Phase Synthesis, Chip-Based Synthesis), By Service (Antibody DNA Synthesis), By Application, By End Use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月19日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，基因合成市場規模將達到 23.7 億美元，到 2025 年將達到 27.5 億美元，到 2033 年將達到 90.8 億美元，在預測期（2026-2033 年）內，複合年成長率將達到 16.1%。

基因合成市場正經歷顯著成長，這主要得益於政府的支持性政策和對合成生物學研究投入的增加。特別是新冠疫情，已促使公共和私人管道投入約80億美元。這場危機刺激了基因合成領域的研究，而用於改進診斷的合成SARS-CoV-2基因片段等創新應用正在推動收入成長。此外，合成DNA技術的進步也為應對新出現的病毒威脅提供了解決方案。同時，在生物技術和製藥領域，對標靶治療的日益重視為基因合成公司帶來了盈利的機會。然而，由於熟練專業人才短缺，市場面臨挑戰，促使各公司與教育機構合作開展培訓舉措，以培養必要的人才。

基因合成市場促進因素

基因合成市場的發展主要得益於分子生物學、基因工程、藥物研發和合成生物學等多個領域的顯著貢獻。這項技術能夠深入闡明基因功能，建構基因改造生物，並開發創新療法。它也有助於建構新型生物系統，拓展科學研究和應用的可能性。隨著基因合成技術在研發活動中的效用不斷擴展，其日益成長的重要性推動了市場需求的成長，這體現了其在推動各種生物技術和醫學創新方面發揮的關鍵作用。

基因合成市場限制因素

基因合成市場面臨許多挑戰，其中最主要的挑戰在於合成遺傳物質可能被濫用，導致有害病原體和微生物的產生，而這引發了倫理方面的擔憂。這些倫理問題要求建立健全的法規結構，以降低風險並確保產業在既定的安全標準內運作。然而，這些監管法規的嚴格性可能會限制市場成長，尤其是在各種應用所需的核准和許可流程方面。因此，雖然遵守監管規定對於維護安全和倫理標準至關重要，但同時也可能限制基因合成領域的創新和發展。

基因合成市場趨勢

基因合成市場正經歷顯著成長，這主要得益於對基因編輯和基因治療創新（尤其是CRISPR-Cas9等先進技術的應用）日益成長的需求。隨著研究人員和生技公司致力於開發精準的基因修飾方法，客製化DNA構建體的需求變得至關重要。這一趨勢凸顯了基因合成在推動基因治療和個人化醫療突破方面的重要作用。此外，人們對這些先進技術的日益關注也加劇了基因合成產業的競爭，促使各公司不斷提升服務水準並創新製程。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2021-2023年營收年比比較

主要企業簡介

Thermo Fisher Scientific Inc.（GeneArt）
GenScript Biotech Corporation
Eurofins Genomics
Integrated DNA Technologies（IDT）
Twist Bioscience
ATUM
Bio Basic Inc.
SBS Genetech Co. Ltd
Azenta Life Sciences
OriGene Technologies Inc.
Bioneer Corporation
Genewiz
Blue Heron Biotech
Creative Biogene
SGI-DNA

結論與建議

簡介目錄

Product Code: SQMIG35H2240

Gene Synthesis Market size was valued at USD 2.37 Billion in 2024 and is poised to grow from USD 2.75 Billion in 2025 to USD 9.08 Billion by 2033, growing at a CAGR of 16.1% during the forecast period (2026-2033).

The gene synthesis market is witnessing significant growth driven by favorable government policies and increasing investment in synthetic biology research. The sector has attracted approximately USD 8.0 billion from public and private funding, particularly spurred by opportunities arising from the COVID-19 pandemic. This crisis has catalyzed exploration in gene synthesis, enhancing revenue potential as researchers pursue innovative applications, such as synthetic SARS-CoV-2 gene segments for diagnostic advancements. Additionally, breakthroughs in synthetic DNA technology offer solutions to emerging viral threats. Meanwhile, the biotechnology and pharmaceutical sectors are increasingly focusing on targeted therapies, indicating profitable opportunities for gene synthesis companies. However, the market faces challenges due to a shortage of skilled professionals, prompting businesses to partner with educational institutions for training initiatives to cultivate necessary talent.

Top-down and bottom-up approaches were used to estimate and validate the size of the Gene Synthesis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Gene Synthesis Market Segments Analysis

Global Gene Synthesis Market is segmented by method, service, application, end use and region. Based on method, the market is segmented into solid-phase synthesis, chip-based synthesis and PCR-based enzyme synthesis. Based on service, the market is segmented into antibody DNA synthesis, viral DNA synthesis and others. Based on application, the market is segmented into vaccine development, therapeutics, diagnostics, research and development and synthetic biology. Based on end use, the market is segmented into academic and research institutes, biopharmaceutical companies and contract research organizations (CROs) and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Gene Synthesis Market

The gene synthesis market is propelled by its essential contributions across multiple domains, including molecular biology, genetic engineering, drug discovery, and synthetic biology. This technology facilitates in-depth exploration of gene functions, the creation of genetically modified organisms, and the development of innovative therapeutic solutions. Additionally, it supports the engineering of new biological systems, broadening the horizon for scientific inquiry and application. As the utility of gene synthesis continues to expand within research and development endeavors, its growing significance fuels an increase in market demand, reflecting its integral role in advancing various biotechnological and medical innovations.

Restraints in the Gene Synthesis Market

The gene synthesis market faces significant challenges due to ethical considerations surrounding the potential misuse of synthesized genetic material, which could enable the creation of harmful pathogens or organisms. These ethical issues necessitate robust regulatory frameworks aimed at mitigating risks, ensuring that the industry operates within defined safety parameters. However, the stringent nature of these regulations can impose limitations on market growth, particularly regarding the process of securing necessary approvals and licenses for various applications. Consequently, while regulatory compliance is essential for maintaining safety and ethical standards, it can also restrict innovation and expansion within the gene synthesis sector.

Market Trends of the Gene Synthesis Market

The gene synthesis market is experiencing notable growth driven by the escalating demand for gene editing and gene therapy innovations, particularly through the application of advanced technologies such as CRISPR-Cas9. As researchers and biotech companies increasingly focus on developing precise genetic modifications, the need for customized DNA constructs becomes critical. This trend highlights the essential role gene synthesis plays in facilitating breakthroughs in gene therapies and personalized medicine. Additionally, the amplified interest in these cutting-edge technologies is fostering a competitive landscape within the gene synthesis industry, motivating companies to enhance their service offerings and innovate their processes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Patent Analysis
Case Studies

Global Gene Synthesis Market Size by Method & CAGR (2026-2033)

Market Overview
Solid-Phase Synthesis
Chip-Based Synthesis
PCR-Based Enzyme Synthesis

Global Gene Synthesis Market Size by Service & CAGR (2026-2033)

Market Overview
Antibody DNA Synthesis
Viral DNA Synthesis
Others

Global Gene Synthesis Market Size by Application & CAGR (2026-2033)

Market Overview
Vaccine Development
Therapeutics
Diagnostics
Research And Development
- Academic Research
- Industrial Research
Synthetic Biology
- Pathway Engineering
- Genome Engineering

Global Gene Synthesis Market Size by End Use & CAGR (2026-2033)

Market Overview
Academic And Research Institutes
Biopharmaceutical Companies
Contract Research Organizations (CROs)

Global Gene Synthesis Market Size & CAGR (2026-2033)

North America (Method, Service, Application, End Use)
- USA
- Canada
Europe (Method, Service, Application, End Use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Method, Service, Application, End Use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Method, Service, Application, End Use)
- Brazil
- Rest of Latin America
Middle East & Africa (Method, Service, Application, End Use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

Thermo Fisher Scientific Inc. (GeneArt)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GenScript Biotech Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Genomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies (IDT)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Twist Bioscience
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ATUM
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio Basic Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SBS Genetech Co. Ltd
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Azenta Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OriGene Technologies Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioneer Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genewiz
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Blue Heron Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Biogene
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SGI-DNA
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments